Safety, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of Ponezumab in subjects with mild-to-moderate Alzheimer's disease

Jae-Hong Lee, Clifford Jack, Martin Bednar, Jaren Landen, Sharon Cohen, Clare Billing, Carol Cronenberger, Scot Styren, Aaron Burstein, Catherine Sattler
  • Alzheimer s & Dementia, July 2012, Elsevier
  • DOI: 10.1016/j.jalz.2012.05.1913
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Martin M Bednar